Scientists at the University of Wisconsin–Madison have uncovered a possible way to protect key cells in the pancreas that are ...

Pregnancy, menopause and hormone therapy may all impact a woman’s lipoprotein(a) level, challenging the mantra of the once-in ...

This review synthesizes evidence that gut microbiota dysbiosis contributes to insulin resistance and symptom severity in ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

Siddhartha Mukherjee, oncologist and author of “The Emperor of All Maladies,” asks: What if we change what a tumor can eat?

Starting Jan. 1, 2026, insulin is expected to be more accessible for Californians after Governor Gavin Newsom approved Senate ...

Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...

Medtrum today unveiled the 300-unit version of its TouchCare Nano tubeless automated insulin delivery patch pump.

Rezolute said on Thursday its therapy aimed at controlling excessive insulin activity in patients with a rare genetic disorder did not show significant benefit in a late-stage trial.

Rezolute said on Thursday its therapy aimed at controlling excessive insulin activity in patients with a rare genetic disorder did not show ‍significant benefit in a late-stage trial. Shares of the ...

Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.